Vasu Rangadass, Ph.D., L7 Informatics President and CEO: “What we provide is a fully integrated platform that has been built over the past 15 years specifically for scientific and regulated environments. Instead of asking organizations to piece together their own solutions, we offer a pre-assembled system that is ready to support AI from the outset.”

L7 Informatics is a technology-driven organization focused on transforming how scientific and research-based businesses operate. Founded with a forward-looking vision, the company addresses one of the biggest barriers to digital transformation: fragmented systems that prevent seamless data flow and efficient workflows. Under the leadership of Vasu Rangadass, L7 Informatics set out to eliminate these inefficiencies by creating a unified platform that enables organizations to fully leverage artificial intelligence and advanced analytics. At the core of its offering is the L7 Enterprise Science Platform (ESP), designed to act as a centralized data and workflow layer across an organization. Instead of relying on disconnected point solutions, L7|ESP^® integrates diverse systems, normalizes data, and enables streamlined, end-to-end processes. This allows businesses to operate faster, reduce costs, and improve decision-making with greater accuracy. The platform supports a range of applications, including laboratory information management systems (LIMS), manufacturing execution systems (MES), digital notebooks, scheduling tools, and asset management solutions.

Beyond technology, L7 Informatics also provides pre-built industry content and implementation services, ensuring customers can quickly adopt and scale the platform to meet evolving scientific and operational demands.

In conversation with Vasu Rangadass, Ph.D., President and CEO of L7 Informatics

L7 Informatics was recently named the Global Leader in Innovation in the 2025 Frost & Sullivan Frost Radar™ and has appeared on the Deloitte Fast 500 for four consecutive years. What do these recognitions signal about your execution and the market’s response?

These recognitions are really a reflection of two things coming together at the right time. First, our team has executed exceptionally well in what is not an easy domain. We operate in highly regulated environments where our platform directly supports the creation of regulated drugs, diagnostics, and even food products. That means precision, reliability, and compliance are not optional; they are fundamental.

Second, the market is beginning to fully grasp why we built L7|ESP® the way we did. With the rapid rise of AI, organizations are now feeling the pressure of fragmented data ecosystems more than ever. They are struggling to harmonize data across multiple point solutions that were never designed to work together. What we anticipated years ago is now becoming a widespread realization. So what we are seeing is not just strong execution on our part, but also a meaningful shift in customer understanding and adoption.

Your platform addresses the persistent issue of data silos by contextualizing data at the source. How does this concept of a “digital unified platform” reshape AI readiness and drug development timelines?

If you look at how drug development typically unfolds today, a significant portion of time is lost in coordination rather than actual science. Teams across departments—and often across organizations—spend countless hours in meetings, exchanging spreadsheets, PowerPoints, and documents. These are not just inefficient workflows; they are fundamentally limiting. The challenge becomes even more pronounced when you extend beyond a single organization. Drug development frequently involves contract research organizations, manufacturing partners, and other external entities. The communication between these parties is still largely document-driven, which introduces delays, interpretation errors, and redundancy.

A unified platform changes this dynamic completely. Instead of unstructured, document-based exchanges, you move toward structured, real-time collaboration where data is contextualized at the point of creation. This reduces both the time and cost associated with bringing a drug to market. You are essentially removing layers of friction that have historically been accepted as unavoidable, but no longer need to be.

L7 Informatics serves a wide spectrum of clients, from large pharmaceutical companies to cancer research centers and ag-bio firms. How does L7|ESP adapt to such diverse requirements?

The flexibility comes from how we approached the problem from the beginning. Rather than building a monolithic application, we broke the system down into seven foundational layers. That is actually where the name “L7” originates. We started with a cloud-agnostic infrastructure layer, then built upward through data and ontology management, workflow orchestration, application development, business intelligence, artificial intelligence, and finally agentic workflows. Each layer builds on the previous one, creating a modular yet cohesive system. This layered architecture allows us to support a wide range of use cases without forcing a one-size-fits-all solution. Whether it is pharmaceutical manufacturing, clinical research, agriculture, or food science, the same platform can be configured to meet different operational and regulatory needs. The adaptability is not an afterthought; it is embedded into the design.

A defining feature of L7|ESP is its ability to integrate with existing systems rather than replacing them. How does this reduce risk and accelerate digital transformation?

This is one of the most important aspects of our platform. Many organizations hesitate to embark on digital transformation because the perceived cost and disruption of replacing legacy systems is simply too high. Rip-and-replace strategies are not only expensive but also risky, especially in regulated environments. With L7|ESP®, we take a different approach. We can layer on top of existing systems, whether they are modern applications or even paper-based processes.

This means organizations can start realizing value immediately without dismantling what they already have in place. By providing real-time operational intelligence, automation, and orchestration across these systems, we effectively enhance their capabilities without requiring wholesale replacement. The result is a much faster path to value, along with significant savings in both time and cost.

The platform includes modular components such as L7|MASTER®, L7|HUB®, and L7|INTELLIGENCE®, along with purpose-built applications. How does this composable model benefit customers?

The composable architecture is about giving customers control over their transformation journey. Not every organization is ready to implement a full-scale digital overhaul at once, and they should not have to. With L7|ESP®, customers can activate different components as needed. For example, they might begin with workflow orchestration and later introduce advanced analytics through L7|INTELLIGENCE®. Recently, we added L7|SYNAPSE^™, which brings agentic AI capabilities into the platform.

Because everything is part of a unified architecture, there is no need to integrate disparate tools from multiple vendors. Customers can expand their capabilities incrementally while still working toward a single source of truth. This approach aligns with varying budgets, timelines, and strategic priorities, making transformation both practical and sustainable.

Industry estimates suggest that fewer than 25% of organizations are truly AI-ready. How does L7 Informatics plan to bridge this gap in the near term?

The gap exists largely because of fragmented systems and incomplete digital foundations. Some organizations are still heavily reliant on paper-based processes, while others have invested in multiple applications that do not communicate effectively with one another. What we provide is a fully integrated platform that has been built over the past 15 years specifically for scientific and regulated environments. Instead of asking organizations to piece together their own solutions, we offer a pre-assembled system that is ready to support AI from the outset.

The analogy I often use is that many companies are trying to build a car by purchasing individual parts and assembling them in their own garage. L7|ESP® is the finished vehicle. It is already engineered, tested, and optimized, allowing customers to focus on driving outcomes rather than building infrastructure.

Looking ahead, what developments are you most excited about for L7 Informatics and its customers?

We are entering a very interesting phase with the introduction of L7|SYNAPSE^™, our agentic AI layer. This represents a significant shift in how systems are implemented and used. Traditionally, deploying platforms like LIMS or ELNs required extensive implementation cycles involving multiple teams, from business analysts to developers and quality assurance specialists. That process could take months or even years. What we are moving toward is a model where scientists and engineers can directly interact with the platform using natural language. Instead of writing detailed requirements documents and waiting for them to be translated into systems, they can simply describe what they need, and the platform will generate it in real time.

This effectively returns control to the end users—the scientists and process engineers who are closest to the work. It removes layers of translation and delay, compressing what used to be lengthy implementation cycles into near-instantaneous outcomes. For the industry as a whole, this is a profound shift. It means faster experimentation, more agile manufacturing processes, and ultimately, a significant acceleration in innovation. For organizations operating in regulated environments, it also means maintaining compliance while dramatically improving efficiency.

“Rather than building a monolithic application, we broke the system down into seven foundational layers. That is actually where the name “L7” originates.”

“The composable architecture is about giving customers control over their transformation journey. Not every organization is ready to implement a full-scale digital overhaul at once, and they should not have to. With L7|ESP^®, customers can activate different components as needed.”